UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 2.908

Sortiert nach

FTY 720

Drugs in R&D, 1999-01, Vol.1 (1), p.78-80

1999

Link zum Volltext

Verfügbarkeit prüfen

t-Sets and some algebraic properties in β S and in ℓ ∈ fty(S)

Semigroup forum, 2002-07, Vol.65 (2), p.285-300

Filali, Mahmoud

2002

Link zum Volltext

Verfügbarkeit prüfen

Fingolimod reduces recurrence of disease activity after natalizumab withdrawal in multiple sclerosis

Journal of neurology, 2013-05, Vol.260 (5), p.1382-1387

2013

Link zum Volltext

Verfügbarkeit prüfen

Oral therapies for treatment of relapsing–remitting multiple sclerosis in Austria: a 2-year comparison using an inverse probability weighting method

Journal of neurology, 2020-07, Vol.267 (7), p.2090-2100

2020

Link zum Volltext

Verfügbarkeit prüfen

Disease Reactivation after Fingolimod Discontinuation in Pregnant Multiple Sclerosis Patients

Neurotherapeutics, 2021-10, Vol.18 (4), p.2598-2607

2021

Link zum Volltext

Verfügbarkeit prüfen

Switching from natalizumab to fingolimod treatment in multiple sclerosis: real life data from the Austrian MS Treatment Registry

Journal of neurology, 2019-11, Vol.266 (11), p.2672-2677

2019

Link zum Volltext

Verfügbarkeit prüfen

Equivalence between Nonlinear H ∈ fty Control Problems and Existence of Viscosity Solutions of HamiltonJacobiIsaacs Equations

Applied mathematics & optimization, 1999-01, Vol.39 (1), p.17-32

Soravia, P.

1999

Link zum Volltext

Verfügbarkeit prüfen

New FTY720-docetaxel nanoparticle therapy overcomes FTY720-induced lymphopenia and inhibits metastatic breast tumour growth

Breast cancer research and treatment, 2017-10, Vol.165 (3), p.531-543

2017

Link zum Volltext

Verfügbarkeit prüfen

Early central vs. peripheral immunological and neurobiological effects of fingolimod—a longitudinal study

Journal of molecular medicine (Berlin, Germany), 2019-09, Vol.97 (9), p.1263-1271

2019

Link zum Volltext

Verfügbarkeit prüfen

Clinical effectiveness of reduced fingolimod dose in relapsing remitting multiple sclerosis—a Portuguese cohort

Neurological sciences, 2021-03, Vol.42 (3), p.1039-1043

2021

Link zum Volltext

Verfügbarkeit prüfen

Fingolimod induces neuroprotective factors in human astrocytes

Journal of neuroinflammation, 2015-09, Vol.12 (1), p.184-184, Article 184

2015

Link zum Volltext

Verfügbarkeit prüfen

Persistence to oral disease-modifying therapies in multiple sclerosis patients

Journal of neurology, 2017-11, Vol.264 (11), p.2325-2329

2017

Link zum Volltext

Verfügbarkeit prüfen

Retrospectively acquired cohort study to evaluate the long-term impact of two different treatment strategies on disability outcomes in patients with relapsing multiple sclerosis (RE.LO.DI.MS): data from the Italian MS Register

Journal of neurology, 2019-12, Vol.266 (12), p.3098-3107

2019

Link zum Volltext

Verfügbarkeit prüfen

Early use of fingolimod is associated with better clinical outcomes in relapsing–remitting multiple sclerosis patients

Journal of neurology, 2022-10, Vol.269 (10), p.5596-5605

2022

Link zum Volltext

Verfügbarkeit prüfen

Risk of multiple sclerosis relapses when switching from fingolimod to cell-depleting agents: the role of washout duration

Journal of neurology, 2022-03, Vol.269 (3), p.1463-1469

2022

Link zum Volltext

Verfügbarkeit prüfen

Comparative effectiveness of delayed-release dimethyl fumarate versus interferon, glatiramer acetate, teriflunomide, or fingolimod: results from the German NeuroTransData registry

Journal of neurology, 2018-12, Vol.265 (12), p.2980-2992

2018

Link zum Volltext

Verfügbarkeit prüfen

The effects of dimethyl fumarate and fingolimod on T-cell lymphocyte proliferation in patients with multiple sclerosis

Irish journal of medical science, 2022-12, Vol.191 (6), p.2759-2762

2022

Link zum Volltext

Verfügbarkeit prüfen

Assessment of Macular Function by Multifocal Electroretinogram in Patients with Multiple Sclerosis Treated with Fingolimod

Advances in therapy, 2021-07, Vol.38 (7), p.3986-3996

2021

Link zum Volltext

Verfügbarkeit prüfen

Transcriptomic Analysis of Peripheral Monocytes upon Fingolimod Treatment in Relapsing Remitting Multiple Sclerosis Patients

Molecular neurobiology, 2021-10, Vol.58 (10), p.4816-4827

2021

Link zum Volltext

Verfügbarkeit prüfen

Effects of Long-term Administration of Low-dose FTY720 on Survival of Murine Cardiac Allograft

Journal of Huazhong University of Science and Technology. Medical sciences, 2012-04, Vol.32 (2), p.199-204

程琪李丹梁慧芳杨宏强窦磊高丹龙新陈义发朱鹏陈孝平

2012

Link zum Volltext

Verfügbarkeit prüfen

Second line use of Fingolimod is as effective as Natalizumab in a German out-patient RRMS-cohort

Journal of neurology, 2013-12, Vol.260 (12), p.2981-2985

2013

Link zum Volltext

Verfügbarkeit prüfen

Effectiveness and baseline factors associated to fingolimod response in a real-world study on multiple sclerosis patients

Journal of neurology, 2018-04, Vol.265 (4), p.896-905

2018

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of alemtuzumab versus fingolimod in RRMS after natalizumab cessation

Journal of neurology, 2019-01, Vol.266 (1), p.165-173

2019

Link zum Volltext

Verfügbarkeit prüfen

Natalizumab promotes activation and pro-inflammatory differentiation of peripheral B cells in multiple sclerosis patients

Journal of neuroinflammation, 2019-11, Vol.16 (1), p.228-228, Article 228

2019

Link zum Volltext

Verfügbarkeit prüfen

Biosorptive efficacy of granular activated carbon in pressure swing adsorption based model cooling system: performance assessment, isotherm modeling and cost evaluation

Environmental science and pollution research international, 2021-06, Vol.28 (23), p.30351-30365

2021

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 2.908

Suche als RSS-Feed

Aktive Filter

SpracheUngarisch

PublikationsformWebseiten

KollektionSpringerLink_现刊

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(2.779)
Mit Volltextzugriff
(2.863)

Publikationsform

Artikel
(2.857)
Reviews
(50)
Berichte
(1)

Sprache

6 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

SpringerLink (Online service)
(2.908)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(2.490)
RCN full-text journals@Ovid
(1.513)
Ingenta
(1.330)
MEDLINE
(836)
EZB Electronic Journals Library
(418)
JSTOR
(409)
BSC - Ebsco (Business Source Ultimate)
(361)
IngentaConnect Journals
(258)
PAIS Index
(120)
Sociological Abstracts
(88)
Applied Social Sciences Index & Abstracts (ASSIA)
(87)
Psychology & Behavioral Sciences Collection
(77)
NUS Single-Journal Subscriptions
(74)
Worldwide Political Science Abstracts
(72)
De Gruyter journals
(47)
Wiley Online Library Journals
(44)
Literature Online (LION)
(40)
Bibliografía de la Literatura Española
(38)
Nexis
(25)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(9)

Menü

Weitere Dienste

Einstellungen

FTY 720

t-Sets and some algebraic properties in β S and in ℓ ∈ fty(S)

Fingolimod reduces recurrence of disease activity after natalizumab withdrawal in multiple sclerosis

Oral therapies for treatment of relapsing–remitting multiple sclerosis in Austria: a 2-year comparison using an inverse probability weighting method

Disease Reactivation after Fingolimod Discontinuation in Pregnant Multiple Sclerosis Patients

Switching from natalizumab to fingolimod treatment in multiple sclerosis: real life data from the Austrian MS Treatment Registry

Equivalence between Nonlinear H ∈ fty Control Problems and Existence of Viscosity Solutions of HamiltonJacobiIsaacs Equations

New FTY720-docetaxel nanoparticle therapy overcomes FTY720-induced lymphopenia and inhibits metastatic breast tumour growth

Early central vs. peripheral immunological and neurobiological effects of fingolimod—a longitudinal study

Clinical effectiveness of reduced fingolimod dose in relapsing remitting multiple sclerosis—a Portuguese cohort

Fingolimod induces neuroprotective factors in human astrocytes

Persistence to oral disease-modifying therapies in multiple sclerosis patients

Retrospectively acquired cohort study to evaluate the long-term impact of two different treatment strategies on disability outcomes in patients with relapsing multiple sclerosis (RE.LO.DI.MS): data from the Italian MS Register

Early use of fingolimod is associated with better clinical outcomes in relapsing–remitting multiple sclerosis patients

Risk of multiple sclerosis relapses when switching from fingolimod to cell-depleting agents: the role of washout duration

Comparative effectiveness of delayed-release dimethyl fumarate versus interferon, glatiramer acetate, teriflunomide, or fingolimod: results from the German NeuroTransData registry

The effects of dimethyl fumarate and fingolimod on T-cell lymphocyte proliferation in patients with multiple sclerosis

Assessment of Macular Function by Multifocal Electroretinogram in Patients with Multiple Sclerosis Treated with Fingolimod

Transcriptomic Analysis of Peripheral Monocytes upon Fingolimod Treatment in Relapsing Remitting Multiple Sclerosis Patients

Effects of Long-term Administration of Low-dose FTY720 on Survival of Murine Cardiac Allograft

Second line use of Fingolimod is as effective as Natalizumab in a German out-patient RRMS-cohort

Effectiveness and baseline factors associated to fingolimod response in a real-world study on multiple sclerosis patients

Efficacy and safety of alemtuzumab versus fingolimod in RRMS after natalizumab cessation

Natalizumab promotes activation and pro-inflammatory differentiation of peripheral B cells in multiple sclerosis patients

Biosorptive efficacy of granular activated carbon in pressure swing adsorption based model cooling system: performance assessment, isotherm modeling and cost evaluation

Aktive Filter

Suchergebnisse filtern